The findings have implications for postremission treatment decisions, including whether NPM1-mutated patients should receive allogeneic...
This is the first treatment approved to help patients with erythropoietic protoporphyria increase their exposure to light.
ROCKVILLE - A new data analytics platform aims to accelerate therapies from bench to bedside for rare diseases.
BARCELONA - The first-in-class oral inhibitor of mIDH1, significantly improved PFS for advanced cholangiocarcinoma in the global, randomized,...
But the new recommendations urge clinicians to refrain from testing asymptomatic nonpregnant women and adult men.
A Lancet Commission report details a series of modeled projections that could point the way.
Health care providers should consider a nonbacterial source as the causative agent for invasive candidiasis infection in immunocompetent patients...
A National Cancer Database study of on survival outcomes for patients with dedifferentiated
liposarcomas found that insurance status, median...